Sign inGet started

Boucher Kelley

Insider CIK 2070437 · APLS Chief People Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
APLS Apellis Pharmaceuticals, I D To issuer deriv2026-05-142026-05-1467,396— $00SEC↗
APLS Apellis Pharmaceuticals, I D To issuer deriv2026-05-142026-05-1445,766— $00SEC↗
APLS Apellis Pharmaceuticals, I D To issuer deriv2026-05-142026-05-1432,976— $00SEC↗
APLS Apellis Pharmaceuticals, I D To issuer2026-05-142026-05-1430,146— $00SEC↗
APLS Apellis Pharmaceuticals, I D To issuer2026-05-142026-05-1430,476— $00SEC↗
APLS Apellis Pharmaceuticals, I D To issuer2026-05-142026-05-1445,095— $00SEC↗
APLS Apellis Pharmaceuticals, I D To issuer2026-05-142026-05-1422,087— $00SEC↗
APLS Apellis Pharmaceuticals, I D To issuer2026-05-142026-05-1430,146— $00SEC↗
APLS Apellis Pharmaceuticals, I A Award2026-05-142026-05-1430,146— $030,146SEC↗
APLS Apellis Pharmaceuticals, I D To issuer2026-05-142026-05-1415,073— $00SEC↗
APLS Apellis Pharmaceuticals, I A Award2026-05-142026-05-1415,073— $015,073SEC↗
APLS Apellis Pharmaceuticals, I U Tender2026-05-142026-05-14127,804— $00SEC↗
APLS Apellis Pharmaceuticals, I A Award2026-01-282026-01-3030,146— $0127,804SEC↗
APLS Apellis Pharmaceuticals, I A Award deriv2025-09-022025-09-0345,766— $045,766SEC↗
APLS Apellis Pharmaceuticals, I A Award2025-09-022025-09-0330,476— $097,658SEC↗
APLS Apellis Pharmaceuticals, I A Award deriv2025-06-092025-06-1167,396$19.39 $1.31M67,396SEC↗
APLS Apellis Pharmaceuticals, I A Award2025-06-092025-06-1145,095— $067,182SEC↗
APLS Apellis Pharmaceuticals, I A Award deriv2025-05-282025-05-2932,976$16.80 $554.0K32,976SEC↗
APLS Apellis Pharmaceuticals, I A Award2025-05-282025-05-2922,087— $022,087SEC↗